McGough C, Baldwin C, Frost G, Andreyev H J N
Department of Medicine and Therapeutics, Imperial College Faculty of Medicine, 4th Floor, Chelsea & Westminster Hospital, 369, Fulham Road, London SW10 9NH, UK.
Br J Cancer. 2004 Jun 14;90(12):2278-87. doi: 10.1038/sj.bjc.6601868.
Up to 12000 patients with gynaecological, urological and rectal cancer undergo radical pelvic radiotherapy annually in the UK. More than 70% develop acute inflammatory changes causing gastrointestinal symptoms during treatment because healthy bowel tissue is encompassed in the radiation field. In total, 50% go on to develop chronic bowel symptoms, which affect quality of life due to permanent changes in the small and large intestine. Nutritional intervention may influence acute and chronic bowel symptoms but the validity of the advice given to patients is not clear. To assess the incidence and significance of malnutrition and to examine the efficacy of therapeutic nutritional interventions used to manage gastrointestinal side effects in patients undergoing pelvic radiotherapy and those with chronic bowel side effects after treatment, a critical review of relevant original studies on human subjects was carried out using a specific set of mesh terms in MEDLINE and EMBASE databases and the Cochrane Library in September 2003. Full texts of all relevant articles were collected and reference lists were checked. Sources of grey literature including conference abstracts and web-based information were also reviewed. A total of 36 papers published in peer-reviewed journals between 1966 and 2003 were identified. In all, 14 randomised controlled trials, 12 prospective cohorts, four retrospective, two qualitative, one validation, one pilot study and two case reports were obtained. These included 2646 patients. Eight articles including three conference abstracts and web-based information were found. None of the studies was definitive because of weakness in methodology. No studies could be combined because the interventions and the end points were different. There is no evidence base for the use of nutritional interventions to prevent or manage bowel symptoms attributable to radiotherapy. Low-fat diets, probiotic supplementation and elemental diet merit further investigation.
在英国,每年有多达12000名患有妇科、泌尿科和直肠癌的患者接受盆腔根治性放疗。超过70%的患者在治疗期间会出现急性炎症变化并导致胃肠道症状,因为健康的肠道组织也在辐射范围内。总体而言,50%的患者会继而出现慢性肠道症状,由于小肠和大肠的永久性改变,这些症状会影响生活质量。营养干预可能会影响急性和慢性肠道症状,但给予患者的建议的有效性尚不清楚。为了评估营养不良的发生率和重要性,并检验用于管理盆腔放疗患者及放疗后有慢性肠道副作用患者胃肠道副作用的治疗性营养干预措施的疗效,2003年9月在MEDLINE、EMBASE数据库以及Cochrane图书馆中使用一组特定的主题词对有关人类受试者的相关原始研究进行了批判性综述。收集了所有相关文章的全文并检查了参考文献列表。还对包括会议摘要和网络信息在内的灰色文献来源进行了综述。共确定了1966年至2003年间在同行评审期刊上发表的36篇论文。总共获得了14项随机对照试验、12项前瞻性队列研究、4项回顾性研究、2项定性研究、1项验证性研究、1项试点研究和2篇病例报告。这些研究共纳入2646名患者。还找到了8篇文章,包括3篇会议摘要和网络信息。由于方法学上的缺陷,没有一项研究是决定性的。由于干预措施和终点不同,没有研究可以合并。没有证据支持使用营养干预措施来预防或管理放疗引起的肠道症状。低脂饮食、补充益生菌和要素饮食值得进一步研究。